Safety and Efficacy of abbreviated (12 hr) Magnesium Sulfate (MgSO4) therapy) vs. traditional 24 hrs therapy after delivery in Severe Preeclampsia: A Randomized Clinical Trial
- Conditions
- Health Condition 1: null- Pregnant women with severe preeclampsia
- Registration Number
- CTRI/2016/07/007076
- Lead Sponsor
- DirectorPGIMER Chandigarh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 240
Inclusion Criteria
1.Women with severe-preeclampsia, diagnosed during ante partum, intrapartum, or postpartum, are eligible for inclusion after delivery.
A diagnostic criterion for severe preeclampsia includes:
•sustained systolic blood pressure of >=160 mm Hg;
•sustained diastolic blood pressure of >=110 mm Hg;
•proteinuria >3 + on dipstick or >=5 g/24- hour urine collection;
•oliguria (urine output <500 mL in 24 hours );
•the presence of persistent headache, visual disturbances, or epigastric or right upper quadrant pain; thrombocytopenia ; impaired liver function; pulmonary edema or cyanosis;
•fetal growth retardation;
•or superimposed severe pre-eclampsia with pre-existing chronic hypertension.
2.Agree to comply with study procedures;
3. > 18 years of age;
4.Give informed consent for study participation
Exclusion Criteria
•Associated maternal diseases;
•Use of illicit drugs or other medications that might interfere with maternal hemodynamics;
•Contraindications to the use of magnesium sulfate: drug hypersensitivity, oliguria with urine output below 25ml/h; anuria (absent urine output), myasthenia gravis.
•Comatosed patients
•Pulmonary oedema
•Oliguria
•Patients who have received MgSO4, Phenytoin, Diazepam before coming to hospital
•Intra cranial bleeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Maternal: Recurrence of fits, signs of magnesium toxicity like loss of knee jerk, respiratory depression, and any other maternal complications like coagulation failure, oliguria, renal failure, and pulmonary oedema will be recorded. Details of labour and delivery will be recorded.Timepoint: Outcome will be assed till48 hours of delivery
- Secondary Outcome Measures
Name Time Method 2.Serum Magnesium level in maternal bloodTimepoint: at 5 mins, 4 hrs, 12 hrs and 24 hrs